Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$16.11

0.14 (0.88%)

13:25
12/07/17
12/07
13:25
12/07/17
13:25

PTC Therapeutics call volume above normal and directionally bullish

Bullish option flow detected in PTC Therapeutics with 1,547 calls trading, 12x expected, and implied vol increasing almost 4 points to 48.19%. Dec-17 17 calls and Feb-18 17 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.01. Earnings are expected on March 15th.

PTCT PTC Therapeutics
$16.11

0.14 (0.88%)

12/04/17
SBSH
12/04/17
NO CHANGE
Target $24
SBSH
Buy
Europe likely to lower eligibility age for PTC's Translarna, says Citi
Citi analyst Joel Beatty believes Europe's Committee for Medicinal Products for Human Use is likely to adopt later this month or in early 2018 the lowering of the age of eligibility to begin treatment with PTC Therapeutics' Translarna to two from the current five years old. The label change is unlikely to drive a substantial increase in sales on its own, but it should help investors be more comfortable in PTC's ability to achieve its guidance of a double digit growth in sales of Translarna in even the most mature regions in 2018, Beatty tells investors in a research note. The analyst keeps a Buy rating on PTC shares with a $24 price target.
11/16/17
JPMS
11/16/17
UPGRADE
Target $15
JPMS
Neutral
PTC Therapeutics upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Anupam Rama upgraded PTC Therapeutics to Neutral with an unchanged price target of $15. The shares at current levels appropriately reflect fair value of commercial Translarna outside the U.S. and peak market potential with Emflaza in the U.S., Rama tells investors in a research note. He sees limited downside given "encouraging performance of these products to date."
10/26/17
BOFA
10/26/17
DOWNGRADE
Target $14
BOFA
Underperform
PTC Therapeutics downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad downgraded PTC Therapeutics to Underperform and cut its price target to $14 from $21 following the receipt of a FDA CRL letter for Ataluren.
10/09/17
10/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Humana (HUM) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor saying insider sales and the August board appointment render it unlikely that acquisition discussions are yet occurring. 2. Viacom (VIAB) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying as media and cable companies jockey "for self-preservation," Charter Communications (CHTR) will likely drop, or significantly curtail, distribution of Viacom's content. 3. PTC Therapeutics (PTCT) downgraded to Underweight from Neutral at JPMorgan with analyst Anupam Rama saying the company's valuation remains at near pre-FDA Advisory Committee meetings levels, despite multiple "mixed / inconclusive / negative" updates recently. 4. Medtronic (MDT) downgraded to Market Perform from Outperform at Wells Fargo with analyst Larry Biegelsen saying a "lull" in major product cycles will drive below average organic sales growth over at least the next few quarters. 5. Symantec (SYMC) was downgraded to Underperform from Market Perform at Cowen and to Hold from Buy at Standpoint Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FLR

Fluor

$41.39

-2.26 (-5.18%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
Fluor selected for lithium, boron mine project in Nevada »

Fluor Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TGT

Target

$69.05

-8.08 (-10.48%)

, BBY

Best Buy

$63.54

1.35 (2.17%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
OnTheFly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks began the session…

TGT

Target

$69.05

-8.08 (-10.48%)

BBY

Best Buy

$63.54

1.35 (2.17%)

CPB

Campbell Soup

$40.57

2.1 (5.46%)

KLIC

Kulicke & Soffa

$21.25

1.345 (6.76%)

A

Agilent

$67.61

5.04 (8.06%)

LIVN

LivaNova

$98.00

-22.28 (-18.52%)

LB

L Brands

$28.43

-6.105 (-17.68%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

BSX

Boston Scientific

$34.05

-1.24 (-3.51%)

NAVI

Navient

$10.74

-1.255 (-10.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 27

    Nov

  • 29

    Nov

  • 04

    Dec

  • 05

    Dec

  • 11

    Dec

  • 03

    Mar

USAT

USA Technologies

$4.96

-0.055 (-1.10%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Hot Stocks
USA Technologies provides update on Nasdaq notification of deficiency »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/20/18
11/20
16:20
11/20/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 20th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMK

GenMark

$5.01

(0.00%)

16:19
11/20/18
11/20
16:19
11/20/18
16:19
Syndicate
Breaking Syndicate news story on GenMark »

GenMark files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

CAL

Caleres

$30.93

-1.165 (-3.63%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Caleres reports Q3 adj. EPS 81c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

RMBL

RumbleON

$5.76

-0.35 (-5.73%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Syndicate
Breaking Syndicate news story on RumbleON »

RumbleON files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 10

    Dec

GPS

Gap

$24.65

-0.79 (-3.11%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Earnings
Gap narrows FY18 EPS view to $2.55-$2.60 from $2.55-$2.70, consensus $2.56 »

Backs FY18 SSS view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

MRCY

Mercury Systems

$46.80

-0.48 (-1.02%)

16:18
11/20/18
11/20
16:18
11/20/18
16:18
Hot Stocks
Mercury Systems gets $6.7M Integrated subsystems order for naval electronics »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$47.83

-0.59 (-1.22%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Thomson Reuters receives court approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

STRM

Streamline Health

$0.90

(0.00%)

, WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Hot Stocks
Streamline Health extends banking agreement with Wells Fargo into 2020 »

Streamline Health…

STRM

Streamline Health

$0.90

(0.00%)

WFC

Wells Fargo

$52.54

-0.77 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/20/18
11/20
16:17
11/20/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$24.65

-0.79 (-3.11%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Earnings
Gap reports Q3 EPS 69c, consensus 68c »

Reports Q3 revenue $4.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/20/18
11/20
16:16
11/20/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

16:14
11/20/18
11/20
16:14
11/20/18
16:14
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker up 11% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Breaking Hot Stocks news story on BJ's Wholesale »

BJ's Wholesale now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FL

Foot Locker

$46.05

-2.74 (-5.62%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker CFO says 'encouraged' by Q3 SSS growth »

"We're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

HTBX

Heat Biologics

$2.04

0.14 (7.37%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Syndicate
Heat Biologics fiels to sell common stock and warrants, no amount given »

A.G.P./Alliance Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.14

-2.65 (-5.43%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Foot Locker reports merchandise inventories $1.305B at November 3 »

As of November 3, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TWI

Titan International

$6.51

-0.4 (-5.79%)

16:13
11/20/18
11/20
16:13
11/20/18
16:13
Hot Stocks
Titan International receives settlement put option notice »

Titan International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$33.93

-0.69 (-1.99%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Mylan announces voluntary recall of select lots of Valsartan-containing products »

Mylan announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

BJ

BJ's Wholesale

$19.83

-0.24 (-1.20%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Earnings
BJ's Wholesale raises FY18 adj. EPS view to $1.22-$1.26 from $1.17-$1.24 »

Consensus $1.23. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PLG

Platinum Group

$0.16

-0.0116 (-6.64%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Hot Stocks
Platinum Group announces reverse 10:1 stock split »

Platinum Group Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFC

China Life Insurance

$10.44

-0.21 (-1.97%)

16:12
11/20/18
11/20
16:12
11/20/18
16:12
Upgrade
China Life Insurance rating change  »

China Life Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$69.11

-8.02 (-10.40%)

16:11
11/20/18
11/20
16:11
11/20/18
16:11
Recommendations
Target analyst commentary  »

Target shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.